Clinical Trials Browser

Phase 2 × Enrolling by invitation × Nivolumab × Clear all

NCT06931613 2025-04-17

Autologous Hematopoietic Stem Cell Transplantation in Pediatric Relapsed or Refractory Hodgkin Lymphoma After Nivolumab Treatment

Phase 2 Enrolling by invitation

Hodgkin Disease, Recurrence